Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

First patients receive experimental cancer drug in groundbreaking trial

NCT ID NCT06248411

Recruiting now Disease control Sponsor: Kyowa Kirin Co., Ltd. Source: ClinicalTrials.gov ↗

Summary

This is the first study in humans testing a new drug called KK2260 for people with advanced or spreading solid tumors. Researchers will first determine the safest dose and then test it in patients with specific cancers like esophageal and head/neck cancer. The main goals are to check the drug's safety, how the body handles it, and see if it shows any early signs of helping control the cancer.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED OR METASTATIC SOLID TUMORS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Aichi Cancer Center Hospital

    RECRUITING

    Nagoya, Aichi-ken, 464-8681, Japan

  • Hiroshima University Hospital

    NOT_YET_RECRUITING

    Hiroshima, Hiroshima, 734-8551, Japan

  • Kanagawa Cancer Center

    RECRUITING

    Yokohama, Kanagawa, 241-8515, Japan

  • Kobe University Hospital

    RECRUITING

    Kobe, Hyōgo, 650-0017, Japan

  • Kumamoto University Hospital

    NOT_YET_RECRUITING

    Kumamoto, Kumamoto, 860-8556, Japan

  • Kyushu Cancer Center

    RECRUITING

    Fukuoka, 811-1347, Japan

  • National Cancer Center Hospital

    RECRUITING

    Chuo-ku, Tokyo, 104-0045, Japan

  • National Cancer Center Hospital East

    RECRUITING

    Kashiwa, Chiba, 277-8577, Japan

  • Osaka International Cancer Institute

    RECRUITING

    Osaka, 540-0008, Japan

  • Saitama Cancer Center

    RECRUITING

    Shinden, Saitama, 362-0806, Japan

  • Shizuoka Cancer Center

    RECRUITING

    Nagaizumi-cho, Shizuoka, 411-8777, Japan

  • The Cancer Institute Hospital of JFCR

    RECRUITING

    Koto-ku, Tokyo, 135-8550, Japan

  • Tohoku University Hospital

    NOT_YET_RECRUITING

    Sendai, Miyagi, 980-8574, Japan

Conditions

Explore the condition pages connected to this study.

ADVANCED OR METASTATIC SOLID TUMORS